Risultati della ricerca - Thomas Collot
- Mostra 1 - 2 risultati su 2
-
1
FOLFIRINOX-3 plus bevacizumab (bFOLFIRINOX3) in chemo-refractory metastatic colorectal cancer: a multicenter phase II trial di Hélène Bellio, Nicolas Roussot, Aurélie Bertaut, Alice Hervieu, Sylvie Zanetta, Zoé Tharin, Julie Vincent, Leila Bengrine, Audrey Hennequin, Jean-Florian Guion, Axelle Boudrant, Thomas Collot, François Ghiringhelli, Jean-David Fumet
Pubblicazione 2025Artigo -
2
Implementation and use of whole exome sequencing for metastatic solid cancer di Manon Réda, Corentin Richard, Aurélie Bertaut, Julie Niogret, Thomas Collot, Jean David Fumet, Julie Blanc, Caroline Truntzer, Isabelle Desmoulins, Sylvain Ladoire, Audrey Hennequin, Laure Favier, Leila Bengrine, Julie Vincent, Alice Hervieu, Jean-Florian Guion Dusserre, Côme Lepage, Pascal Foucher, Christophe Borg, Juliette Albuisson, Laurent Arnould, Sophie Nambot, Laurence Faivre, Romain Boidot, François Ghiringhelli
Pubblicazione 2020Artigo
Strumenti per la ricerca:
Soggetti correlati
Cancer
Internal medicine
Medicine
Astrobiology
Bevacizumab
Bioinformatics
Biology
Chemotherapy
Clinical trial
Colorectal cancer
Computational biology
DNA
DNA sequencing
Exome
Exome sequencing
Gene
Genetics
Mutation
Oncology
Oxaliplatin
Phases of clinical research
Physics
Refractory (planetary science)